Fmoc-L-threonine monohydrate

Fmoc-L-threonine monohydrate is an Fmoc-protected L-threonine derivative that incorporates a chiral α-amino acid framework with a side-chain bearing a hydroxyl group, enabling stereochemically defined chemistry at the amino terminus while retaining functional reactivity on the threonine side chain. The structure contains an Fmoc carbamate that suppresses free amine reactivity during peptide assembly and can be removed under standard base conditions to regenerate an amine for subsequent coupling cycles. The monohydrate form introduces controlled water content that can affect handling and dissolution behavior in synthesis workflows, while the free carboxyl functionality is typically present as an acid form suitable for activation and amide bond formation. The combination of a protected amino group, a carboxylic acid, and an unprotected side-chain hydroxyl supports orthogonal derivatization strategies, including side-chain protection when selective functionalization or downstream conjugation is required.

1. Peptide Synthesis

Fmoc-L-threonine monohydrate serves as a peptide building block for solid-phase peptide synthesis and related protected amino acid chemistry where stepwise N-terminal deprotection and coupling are required. The Fmoc carbamate on the α-amino group enables controlled peptide chain elongation, while the L-stereocenter preserves the natural threonine configuration that governs amide geometry and side-chain orientation in the growing sequence. The side-chain hydroxyl can be left available for hydrogen-bonding interactions in peptide analogs or can be temporarily protected to prevent competing reactions during coupling and post-assembly transformations. The resulting threonine-containing peptides and peptide fragments can be used for structure-activity relationship studies, receptor-binding investigations, and protein-interaction mapping where hydroxyl-bearing residues are functionally informative.

2. Side-Chain Functionalization

Fmoc-L-threonine monohydrate supports amino acid derivatization workflows that target the threonine hydroxyl for selective functional group installation after peptide assembly or in solution-phase intermediate synthesis. The preserved side-chain hydroxyl enables conversion to ether or ester derivatives, participation in oxidation/reduction sequences, and orthogonal modification strategies that can be scheduled relative to Fmoc deprotection and carboxyl activation steps. The Fmoc-protected amino group helps maintain chemoselectivity by preventing unwanted amide formation or side reactions during hydroxyl-specific transformations. Downstream products include hydroxyl-functional peptide analogs and chemically modified amino acid intermediates that can be used in chemical biology research, biomolecule labeling schemes, and peptidomimetic scaffold construction where threonine-side-chain chemistry is a key design element.

3. Protein Engineering

Fmoc-L-threonine monohydrate can be applied in protein engineering and synthetic protein chemistry contexts where threonine residues are incorporated to tune phosphorylation-like motifs, hydrogen-bond networks, or solvent-exposed functional sites. The L-threonine stereochemistry and Fmoc-protected α-amino group facilitate reliable incorporation into peptide segments that later undergo assembly into larger constructs or conjugation-ready fragments. The side-chain hydroxyl provides a handle for installing additional functionalities that may mimic post-translational modification patterns or enable crosslinking chemistry under controlled conditions. The resulting threonine-containing engineered biomolecules and peptide domains can be used to probe sequence-dependent folding behavior, interaction surfaces, and substrate recognition features in biochemical assays.

4. Chemical Biology Probes

Fmoc-L-threonine monohydrate is suitable for chemical biology applications that require incorporation of a hydroxyl-bearing residue into probe molecules for controlled reactivity and molecular recognition. The Fmoc-protected amino group supports sequential synthesis of labeled peptides or peptidomimetic fragments, while the side-chain hydroxyl enables conjugation handles such as linkers, affinity tags, or reactive groups introduced via hydroxyl derivatization. The chiral α-carbon derived from L-threonine helps maintain stereochemical fidelity that can influence binding orientation and local conformational preferences in target-binding assays. The compound can therefore serve as a route to hydroxyl-functional probe libraries and analytical standards used to study biomolecular interactions, enzyme-substrate preferences, and structure-function relationships in amino acid-based systems.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-L-threonine monohydrate supports pharmaceutical manufacturing workflows that rely on protected amino acid intermediates for peptide ingredient synthesis and process chemistry development. The Fmoc group provides a robust protection strategy for the α-amino functionality during activation of the carboxylic acid and subsequent amide bond formation steps, aligning with industrially scalable peptide coupling methodologies. The threonine side-chain hydroxyl can be managed through orthogonal protection or controlled derivatization to meet specification requirements for downstream conjugation, stability, or purification behavior. The monohydrate-containing solid form can be integrated into fine chemical production routes where reproducible handling and predictable reactivity are required for consistent peptide building block consumption and intermediate generation.

1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

2. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

4. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate